Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Liver Cancer Disparities in American Indian and Alaska Native Persons
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Impact of Hepatitis B Immunoglobulins in Patients With Chronic Hepatitis B on Hepatocellular Carcinoma - a Proof of Concept Study
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer
- Status
- WITHDRAWN
- Phase
- N/A
Pharmacogenetic Study in Hepatocellular Carcinoma Patients.
- Status
- COMPLETED
- Phase
- N/A
The Surveillance of Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
A Phase I, Open-label Study to Assess the Safety and Efficacy of Poly-ICLC Plus Nivolumab in Unresectable Hepatocellular Carcinoma Patients
- Status
- UNKNOWN
- Phase
- PHASE1
RFA for Treatment of Intermediate Stage HCC
- Status
- COMPLETED
- Phase
- NA
Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Assessing the Prognosis of TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for HCC by Using Clinical and Imaging Biomarkers
- Status
- UNKNOWN
- Phase
- N/A
Value of Negative 18FDG PET/CT in Milan Out, Up-to-seven in, HCC Transplant Candidates
- Status
- RECRUITING
- Phase
- N/A
Plan for Microwave Thermal Field
- Status
- UNKNOWN
- Phase
- NA
Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by Immunotherapy
- Status
- RECRUITING
- Phase
- N/A
Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning
- Status
- RECRUITING
- Phase
- N/A
CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3